Tumor Tracking Systems Market Introduction
Tumor tracking is important for radiotherapy treatment to deliver sufficient radiation dose without damaging the surrounding healthy tissue. Tracing of tumor in a patient's body has turned into a troublesome assignment as a result of move in patient's position, change of tumor area during a progression of treatment, and tumor development because of breath. Now and again, picture guided radiotherapy confines the tumor continuously. Tumor following frameworks give a quicker and progressively productive technique for the assessment and following of tumor cells. For the better comprehension of the malignant growth type, transformations, and cell lifecycle prompting powerful administration of disease, tumor tracking systems give a quicker and progressively productive technique for the assessment of treatment.
Tumor Tracking Systems Market - Competitive Landscape
Varian Medical Systems, Inc., Accuray Incorporated, and Brainlab are the major players operating in the global tumor tracking systems market. Value-added discounts and new product line development are the key strategies adopted by these players to sustain market share.
Need an Overview of the Report on Tumor Tracking Systems Market? Ask for the Brochure here
Varian Medical Systems, Inc.
Varian Medical Systems, Inc. is headquartered in Palo Alto, California, the U.S. It is a leading provider of tumor tracking systems across the world. The company develops products in the field of radiotherapy, radiosurgery, X-ray tube technology, cargo screening, and non-destructive testing. In 2017, Varian Medical Systems launched a revolutionary device called HyperArc, which helps clinicians to deliver more compact radiation doses that closely conform to the size, shape, and location of tumor.
Headquartered in the U.S., Accuray Incorporated develops, manufactures, and sells radiation oncology systems that make cancer treatment shorter, safer, smarter, and more effective. The company has installed more than 850 systems in over 50 countries. It recently launched Synchrony motion tracking system to provide real time tracking of tumor motion during treatment.
Elekta AB is a Sweden-based human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care. Its solutions in oncology and neurosurgery are used in over 5,000 hospitals globally.
Tumor Tracking Systems Market Dynamics
Advancements in Tumor Tracking Systems Drive Demand
Devices such as Calypso, which is based on electromagnetic interference, that provides a real-time tumor tracking modality with benefits such as no requirement of ionizing radiation during localization of tumor and real-time feedback so that action can be taken to limit the influence of intrafraction motion. Such devices help surgeons to perform the treatment with minimal complication to patients. Hence, technological advancements drive demand for tumor tracking systems.
Stuck in a Neck-to-Neck Competition with other Brands? Request a Custom Report on “Tumor Tracking Systems Market” here
North America Dominated Global Tumor Tracking Systems Market in 2018
According to the National Cancer Institutes, more than 1.7 million people in the U.S. were diagnosed with cancer in 2018; of these, 609,640 people succumbed to the disease. Large patient base, high awareness, availability of reimbursement, and high cost of the products in the U.S. propel the tumor tracking systems market in North America. However, rise in awareness and adoption of advanced treatments in the health care systems in countries such as Japan, India, and Singapore are expected to augment the tumor tracking systems market in Asia Pacific.
Tumor Tracking Systems Market Segmentation
In terms of device type, the global tumor tracking systems market can be classified into:
- Direct Tumor Tracking Systems
- Respiratory Tracking Systems
Based on application, the global tumor tracking systems market can be categorized into:
- Prostate Cancer
- Lung Cancer
- Breast Cancer
In terms of end-user, the global tumor tracking systems market can be divided into:
- Cancer Research Institutes
- Ambulatory Surgical Centers
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.